{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:40:10Z","timestamp":1789191610985,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,6]]},"DOI":"10.1093\/jnci\/dji173","type":"journal-article","created":{"date-parts":[[2005,7,6]],"date-time":"2005-07-06T06:17:44Z","timestamp":1120630664000},"page":"975-980","source":"Crossref","is-referenced-by-count":150,"title":["A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer Incidence"],"prefix":"10.1093","volume":"97","author":[{"given":"Eric J.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Mondul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari J.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Jane","family":"Henley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia E.","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,6]]},"reference":[{"key":"key\n\t\t\t\t20171013041227_BIB1","doi-asserted-by":"crossref","unstructured":"Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst2002 ; 94 : 252 \u201366.","DOI":"10.1093\/jnci\/94.4.252"},{"key":"key\n\t\t\t\t20171013041227_BIB2","doi-asserted-by":"crossref","unstructured":"Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med2003 ; 348 : 891 \u20139.","DOI":"10.1056\/NEJMoa021735"},{"key":"key\n\t\t\t\t20171013041227_BIB3","doi-asserted-by":"crossref","unstructured":"Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med2003 ; 348 : 883 \u201390.","DOI":"10.1056\/NEJMoa021633"},{"key":"key\n\t\t\t\t20171013041227_BIB4","unstructured":"Drago JR, Al-Mondhiry HA. The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res1984 ; 4 : 391 \u20134."},{"key":"key\n\t\t\t\t20171013041227_BIB5","doi-asserted-by":"crossref","unstructured":"Pollard M, Luckert M. The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cells. Prostate1986 ; 8 : 81 \u20136.","DOI":"10.1002\/pros.2990080110"},{"key":"key\n\t\t\t\t20171013041227_BIB6","doi-asserted-by":"crossref","unstructured":"Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, et al. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res2004 ; 64 : 3334 \u201343.","DOI":"10.1158\/0008-5472.CAN-03-2422"},{"key":"key\n\t\t\t\t20171013041227_BIB7","doi-asserted-by":"crossref","unstructured":"Hussain T, Gupta S, Mukhtar H. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett2003 ; 191 : 125 \u201335.","DOI":"10.1016\/S0304-3835(02)00524-4"},{"key":"key\n\t\t\t\t20171013041227_BIB8","doi-asserted-by":"crossref","unstructured":"Habel LA, Zhao W, Stanford JL. Daily aspirin use and prostate cancer risk in a large multiracial cohort in the U.S. Cancer Causes Control2002 ; 13 : 427 \u201334.","DOI":"10.1023\/A:1015788502099"},{"key":"key\n\t\t\t\t20171013041227_BIB9","unstructured":"Leitzmann MF, Stampfer MJ, Ma J, Chan JM, Colditz GA, Willett WC, et al. Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev2002 ; 11 : 1108 \u201311."},{"key":"key\n\t\t\t\t20171013041227_BIB10","doi-asserted-by":"crossref","unstructured":"Perron L, Bairati I, Moore L, Meyer F. Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer2003 ; 106 : 409 \u201315.","DOI":"10.1002\/ijc.11250"},{"key":"key\n\t\t\t\t20171013041227_BIB11","doi-asserted-by":"crossref","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev2004 ; 13 : 649 \u201353.","DOI":"10.1158\/1055-9965.649.13.4"},{"key":"key\n\t\t\t\t20171013041227_BIB12","doi-asserted-by":"crossref","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ2000 ; 320 : 1642 \u20136.","DOI":"10.1136\/bmj.320.7250.1642"},{"key":"key\n\t\t\t\t20171013041227_BIB13","doi-asserted-by":"crossref","unstructured":"Paganini-Hill A, Chao A, Ross R, Henderson B. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ1989 ; 299 : 1247 \u201350.","DOI":"10.1136\/bmj.299.6710.1247"},{"key":"key\n\t\t\t\t20171013041227_BIB14","doi-asserted-by":"crossref","unstructured":"Schreinmachers D, Everson R. Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology1994 ; 5 : 138 \u201346.","DOI":"10.1097\/00001648-199403000-00003"},{"key":"key\n\t\t\t\t20171013041227_BIB15","unstructured":"Neugut AI, Rosenberg DJ, Ahsan H, Jacobson JS, Wahid N, Hagan M, et al. Association between coronary heart disease and cancers of the breast, prostate and colon. Cancer Epidemiol Biomarkers Prev1998 ; 7 : 869 \u201373."},{"key":"key\n\t\t\t\t20171013041227_BIB16","doi-asserted-by":"crossref","unstructured":"Norrish A, Jackson R, McCrae C. Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer1998 ; 77 : 511 \u20135.","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X"},{"key":"key\n\t\t\t\t20171013041227_BIB17","doi-asserted-by":"crossref","unstructured":"Irani J, Ravery V, Pariente JL, Chartier-Kastler E, Lechevallier E, Soulie M, et al. Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. J Urol2002 ; 168 : 1985 \u20138.","DOI":"10.1016\/S0022-5347(05)64277-2"},{"key":"key\n\t\t\t\t20171013041227_BIB18","doi-asserted-by":"crossref","unstructured":"Friis S, Sorensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer2003 ; 88 : 684 \u20138.","DOI":"10.1038\/sj.bjc.6600760"},{"key":"key\n\t\t\t\t20171013041227_BIB19","doi-asserted-by":"crossref","unstructured":"Nelson JE, Harris RE. Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs: Results of a case-control study. Oncol Rep2000 ; 7 : 169 \u201370.","DOI":"10.3892\/or.7.1.169"},{"key":"key\n\t\t\t\t20171013041227_BIB20","doi-asserted-by":"crossref","unstructured":"Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. A population-based study of daily non-steroidal anti-inflammatory drug use and prostate cancer. Mayo Clin Proc2002 ; 77 : 219 \u201325.","DOI":"10.4065\/77.3.219"},{"key":"key\n\t\t\t\t20171013041227_BIB21","doi-asserted-by":"crossref","unstructured":"Sorensen HT, Friis S, Norgard B, Blot WJ, McLaughlin JK, Ekbom A, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer2003 ; 88 : 1687 \u201392.","DOI":"10.1038\/sj.bjc.6600945"},{"key":"key\n\t\t\t\t20171013041227_BIB22","doi-asserted-by":"crossref","unstructured":"Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort\u2013rationale, study design and baseline characteristics. Cancer2002 ; 94 : 2490 \u2013501.","DOI":"10.1002\/cncr.101970"},{"key":"key\n\t\t\t\t20171013041227_BIB23","doi-asserted-by":"crossref","unstructured":"Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill JL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol1998 ; 147 : 556 \u201362.","DOI":"10.1093\/oxfordjournals.aje.a009487"},{"key":"key\n\t\t\t\t20171013041227_BIB24","doi-asserted-by":"crossref","unstructured":"Calle EE, Terrell DD. Utility of the national death index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol1993 ; 137 : 235 \u201341.","DOI":"10.1093\/oxfordjournals.aje.a116664"},{"key":"key\n\t\t\t\t20171013041227_BIB25","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. Sixth ed. New York (NY): Springer; 2002 ."},{"key":"key\n\t\t\t\t20171013041227_BIB26","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life tables (with discussion). J R Stat Soc B1972 ; 34 : 187 \u2013220.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"key\n\t\t\t\t20171013041227_BIB27","doi-asserted-by":"crossref","unstructured":"Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, et al. Aspirin and other non-steroidal anti-inflammatory drugs and breast cancer incidence in a large US cohort. Cancer Epidemiol Biomarkers Prev2005 ; 14 : 264 \u20137.","DOI":"10.1158\/1055-9965.261.14.1"},{"key":"key\n\t\t\t\t20171013041227_BIB28","doi-asserted-by":"crossref","unstructured":"Kleinbaum DG. Survival analysis: a self-learning Text. New York (NY): Springer; 1996 .","DOI":"10.1007\/978-1-4757-2555-1"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/97\/13\/975\/7686226\/dji173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T17:58:56Z","timestamp":1683136736000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/97\/13\/975\/2521260\/A-Large-Cohort-Study-of-Aspirin-and-Other"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,6]]},"references-count":28,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2005,7,6]]},"published-print":{"date-parts":[[2005,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dji173","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,7,6]]},"published":{"date-parts":[[2005,7,6]]}}}